1. Wang, Haizhou, Zhou, Yabo, Zhang, Yangyang, Zhao, Qiu, Wang, Fan. . Subtyping of microsatellite stability colorectal cancer reveals guanylate binding protein 2 (GBP2) as a potential immunotherapeutic target. In Journal for immunotherapy of cancer, 10, . doi:10.1136/jitc-2021-004302. https://pubmed.ncbi.nlm.nih.gov/35383115/
2. Li, Xiaohui, Liu, Jialu, Zeng, Mengru, Wang, Wenpeng, Xiao, Li. 2023. GBP2 promotes M1 macrophage polarization by activating the notch1 signaling pathway in diabetic nephropathy. In Frontiers in immunology, 14, 1127612. doi:10.3389/fimmu.2023.1127612. https://pubmed.ncbi.nlm.nih.gov/37622120/
3. Feng, Dechao, Zhu, Weizhen, Shi, Xu, Yang, Lu, Han, Ping. 2023. Immune-related gene index predicts metastasis for prostate cancer patients undergoing radical radiotherapy. In Experimental hematology & oncology, 12, 8. doi:10.1186/s40164-022-00367-x. https://pubmed.ncbi.nlm.nih.gov/36635777/
4. Peng, Zhi, Zhang, Ruoyu, Kuang, Xiaolin, Teng, Zhaowei, Lu, Sheng. 2022. Single-cell RNA-seq reveals interferon-induced guanylate-binding proteins are linked with sarcopenia. In Journal of cachexia, sarcopenia and muscle, 13, 2985-2998. doi:10.1002/jcsm.13091. https://pubmed.ncbi.nlm.nih.gov/36162807/
5. Wang, Yunfei, Pan, Jiadong, An, Fangmei, Qian, Zhengtao, Zhan, Qiang. 2023. GBP2 is a prognostic biomarker and associated with immunotherapeutic responses in gastric cancer. In BMC cancer, 23, 925. doi:10.1186/s12885-023-11308-0. https://pubmed.ncbi.nlm.nih.gov/37784054/
6. Ye, Shujiang, Li, Siyu, Qin, Lei, Ye, Nan, Li, Guangyuan. 2023. GBP2 promotes clear cell renal cell carcinoma progression through immune infiltration and regulation of PD‑L1 expression via STAT1 signaling. In Oncology reports, 49, . doi:10.3892/or.2023.8486. https://pubmed.ncbi.nlm.nih.gov/36660930/
智鼠故事 
